Various clinical trials have evaluated the clinical value of an initial dose intensification of imatinib in CML-CP patients (an overview of the most important response rates is given in Table 1).

Inhibikase Therapeutics ( (IKT) ) has provided an announcement. Inhibikase Therapeutics, Inc. released a new presentation on ...

Imatinib is a tyrosine kinase inhibitor widely used in the treatment of chronic myelogenous leukemia. Originally designed to target the chronic-myelogenous-leukemia-specific tyrosine kinase bcr ...

Older men who find themselves living alone tend to have fewer close personal relationships than older women. They’re ...

Of the compounds Nick sent me for testing, I identified CGP 57148B (also known as STI571, Gleevec, Glivec or imatinib mesylate) as the most effective at killing CML cells without harming normal ...

Background and Objective: Imatinib mesylate is the first effective therapy for advanced unresectable gastrointestinal stromal tumours (GIST). Adoption of this therapy in clinical practice is ...

A key gene that could enhance the treatment success rates of chronic myeloid leukemia (CML) has been discovered by ...

A woman whose lip swelled up unexpectedly during a lip filler procedure discovered it was because she had leukaemia. Edita ...

Researchers are advising against the interruption of treatment with Gleevec among patients with advanced gastrointestinal ...

Blood cancer is not always fatal and advancements in treatment offer significant hope. Misconceptions exist, such as it being ...

Most patients diagnosed with chronic-phase chronic myeloid leukemia (CP-CML) who achieved a deep molecular response on ...

Find all the commercial and brand names of generic drug called Imatinib. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...